CRYSTALLINE FORMS OF AN MCL-1 INHIBITOR
Disclosed herein are crystalline forms of (4S,7aR,9aR, 10R, 11E, 14S, 15R)-6'-chloro-10-methoxy-14, 15- dimethyl-10-{[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl}-3',4',7a,8,9,9a,10, 13, 14, 15-decahydro- 2'H, 3H, 5H-spiro[1,19-etheno-1616-cyclobuta[i] [1,4] oxazepino[3,...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Disclosed herein are crystalline forms of (4S,7aR,9aR, 10R, 11E, 14S, 15R)-6'-chloro-10-methoxy-14, 15- dimethyl-10-{[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl}-3',4',7a,8,9,9a,10, 13, 14, 15-decahydro- 2'H, 3H, 5H-spiro[1,19-etheno-1616-cyclobuta[i] [1,4] oxazepino[3, 4-f] [1,2,7]thiadiazacyclohexadecine-4,1'- naphthalene]-16, 16, 18(7H, 17H)-trione (AMG 397): (AMG 397), hydrates, and solvates thereof. Also disclosed are methods of making the crystalline forms, and methods of treating diseases and disorders with the crystalline forms. |
---|